Stock Earnings

Question 1

Gyre Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Gyre Therapeutics Inc'in toplam varlıkları $125 olup, net profit $12'dir.

Question 2

GYRE'ün temel finansal oranları nelerdir?

Accepted Answer

Gyre Therapeutics Inc'in cari oranı 2.01, net kâr marjı 11.42, hisse başına satış $1.02'dir.

Question 3

Gyre Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Gyre Therapeutics Inc largest revenue segment is Gyre Pharmaceuticals, at a revenue of 105,757,000 in the most earnings release.For geography, China is the primary market for Gyre Therapeutics Inc, at a revenue of 105,757,000.

Question 4

Gyre Therapeutics Inc kârlı mı?

Accepted Answer

yes, son mali tablolara göre Gyre Therapeutics Inc'in net profit $12'dir.

Question 5

Gyre Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Gyre Therapeutics Inc'in yükümlülüğü 62'dir.

Question 6

Gyre Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Gyre Therapeutics Inc'in toplam tedavüldeki hisse sayısı 86.3'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	102	105	113	0	7	20
Revenue Growth (YoY)	-38%	-7%	--	-100%	-65%	--
Cost of Revenue	4	3	4	0	7	9
Gross Profit	98	101	108	0	0	11
Selling, General & Admin	75	73	75	16	18	16
Research & Development	13	12	13	12	68	52
Operating Expenses	88	85	89	29	87	68
Other Non Operating Income (Expenses)	1	5	-10	0	0	0
Pretax Income	11	23	-76	-7	-87	-56
Income Tax Expense	2	5	8	0	--	--
Net Income	4	12	-92	-8	-87	-56
Net Income Growth	-105%	-112.99%	1,050%	-91%	55%	2%
Shares Outstanding (Diluted)	102.7	102.29	65.83	2.1	2.04	1.28
Shares Change (YoY)	-2%	55%	3,035%	3%	59%	60%
EPS (Diluted)	0.04	0.11	-1.41	-3.92	-43.1	-43.93
EPS Growth	-106%	-108%	-64%	-91%	-2%	-36%
Free Cash Flow	-1	-6	17	-33	-84	-55
Free Cash Flow Per Share	0	-0.05	0.25	-15.71	-41.17	-42.96
Gross Margin	96.07%	96.19%	95.57%	0%	0%	55%
Operating Margin	8.82%	15.23%	16.81%	0%	-1,242.85%	-280%
Profit Margin	3.92%	11.42%	-81.41%	0%	-1,242.85%	-280%
Free Cash Flow Margin	-0.98%	-5.71%	15.04%	0%	-1,200%	-275%
EBITDA	11	17	20	-29	-87	-56
EBITDA Margin	10.78%	16.19%	17.69%	0%	-1,242.85%	-280%
D&A For EBITDA	2	1	1	0	0	0
EBIT	9	16	19	-29	-87	-56
EBIT Margin	8.82%	15.23%	16.81%	0%	-1,242.85%	-280%
Effective Tax Rate	18.18%	21.73%	-10.52%	0%	--	--

Gyre Therapeutics Inc (GYRE) Price

GYRE Stock Price Chart

GYRE Income

Follow-Up Questions